RECURSION PHARMACEUTICALS, INC. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
RXRX on Nasdaq
Location
Salt Lake City, UT
Fiscal year end
31 December
Latest financial report
25 Feb 2026

Quick Takeaways

  • RXRX - RECURSION PHARMACEUTICALS, INC. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Invested Capital -151%.

What Changed

  • Return On Invested Capital YoY change: <span class="text-red-600">-16%</span>.
  • Most recent SEC facts end date: 31 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Return On Invested Capital -151.3%, Return On Equity -59.5%, and Return On Assets -27.7%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

26.7/100

Weak Confidence high

Return On Invested Capital

-151%

Metric score 0.0/100

Return On Equity

-60%

Metric score 0.0/100

Return On Assets

-28%

Metric score 0.0/100

Financial Health

Current Ratio
5.5x
Quick Ratio
5.2x
Debt to Equity
0.07x

Strengths

Debt-to-equity and Revenues YoY

Watchpoints

Return On Invested Capital, Return On Equity, and Return On Assets

Key metrics snapshot

Return On Equity

-60%

YoY: -3.8%

Industry median: -47% (n=218)

View history

Return On Assets

-28%

YoY: +0.02%

Industry median: -44% (n=217)

View history

Operating Margin

-329%

YoY: +6.6%

Industry median: -263% (n=94)

View history

Current Ratio

5.5x

YoY: +44%

Industry median: 3.67x (n=218)

View history

Quick Ratio

5.2x

YoY:

Industry median: 2.03x (n=83)

View history

Debt-to-equity

0.07x

YoY: -54%

Industry median: 0.31x (n=169)

View history

Revenues YoY

27%

YoY:

Industry median: 11% (n=96)

View history

NetIncomeLoss YoY

-39%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Invested Capital -151% -16%
Return On Equity -60% -3.8%
Return On Assets -28% +0.02%
Operating Margin -329% +6.6%

Financial Health

Metric Latest value YoY change
Current Ratio 5.5x +44%
Quick Ratio 5.2x
Debt-to-equity 0.07x -54%

Growth

Metric Latest value YoY change
Revenues YoY 27%
NetIncomeLoss YoY -39%

Share Metrics

Metric Latest value YoY change
Common Stock, Shares, Outstanding 528,182,693 +33%
Common Stock, Value, Issued $5,000 +25%
Weighted Average Number of Shares Outstanding, Basic 447,446,109 +63%
Weighted Average Number of Shares Outstanding, Diluted 447,446,109 +63%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $74,681,000 +27%
Research and Development Expense $475,271,000 +51%
General and Administrative Expense $176,589,000 -0.9%
Costs and Expenses $722,813,000 +34%
Operating Income (Loss) $648,132,000 -35%
Nonoperating Income (Expense) $3,237,000 -77%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $644,895,000 -39%
Income Tax Expense (Benefit) $136,000 +88%
Earnings Per Share, Basic -1.44 +15%
Earnings Per Share, Diluted -1.44 +15%
Cash and Cash Equivalents, at Carrying Value $743,294,000 +25%
Other Assets, Current $28,566,000 -25%
Assets, Current $812,845,000 +14%
Deferred Income Tax Assets, Net $957,000 -51%
Property, Plant and Equipment, Net $103,931,000 -26%
Operating Lease, Right-of-Use Asset $45,339,000 -31%
Intangible Assets, Net (Excluding Goodwill) $309,903,000 -7.7%
Goodwill $162,158,000 +8.9%
Other Assets, Noncurrent $12,754,000 +45%
Assets $1,474,130,000 +1.8%
Accounts Payable, Current $18,118,000 -16%
Employee-related Liabilities, Current $31,771,000 -38%
Accrued Liabilities, Current $70,230,000 -14%
Contract with Customer, Liability, Current $37,605,000 -39%
Liabilities, Current $147,707,000 -21%
Long-term Debt and Lease Obligation $9,564,000 -50%
Contract with Customer, Liability, Noncurrent $114,012,000 -4%
Deferred Income Tax Liabilities, Net $23,255,000 +40%
Operating Lease, Liability, Noncurrent $46,647,000 -31%
Other Liabilities, Noncurrent $2,080,000 -56%
Liabilities $343,265,000 -17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $36,717,000
Retained Earnings (Accumulated Deficit) $2,076,002,000 -45%
Stockholders' Equity Attributable to Parent $1,130,865,000 +9.3%
Liabilities and Equity $1,474,130,000 +1.8%
Common Stock, Shares Authorized 2,000,000,000 0%
Common Stock, Shares, Issued 528,182,693 +33%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $753,921,000 +25%
Deferred Tax Assets, Valuation Allowance $665,371,000 +43%
Deferred Tax Assets, Gross $719,596,000 +33%
Operating Lease, Liability $59,310,000 -27%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $600,405,000 -27%
Lessee, Operating Lease, Liability, to be Paid $72,683,000 -28%
Property, Plant and Equipment, Gross $193,145,000 -5.2%
Operating Lease, Liability, Current $12,663,000 -8.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $17,827,000 -13%
Lessee, Operating Lease, Liability, to be Paid, Year One $17,467,000 -9.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.079 +2.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $13,373,000 -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three $15,171,000 -27%
Deferred Tax Assets, Operating Loss Carryforwards $445,440,000 +62%
Unrecognized Tax Benefits $11,803,000 +75%
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,201,000 -51%
Additional Paid in Capital $3,170,145,000 +28%
Amortization of Intangible Assets $50,300,000 +168%
Deferred Tax Assets, Net of Valuation Allowance $54,225,000 -28%
Share-based Payment Arrangement, Expense $110,018,000 +38%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY